[Business Wire] – Pfizer Inc. today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials.
Read more on this.
Pfizer Inc. (PFE), with a current value of $202.37B, opened this morning at … [visit site to read more]
Similar posts:- Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting
- Company Update – Morgan Stanley (NYSE:MS) – Exclusive: U.S. expands China hiring probe to Morgan Stanley
- AbbVie Inc. (NYSE:ABBV) ~ AbbVie’s hepatitis C treatment helps 96 pct of patients in trial
